The long-term suitability of hydrolysed infant formula
is a topic covered in the Evidence-Based Medicine Guidelines
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
"the Long-term Suitability of Hydrolysed Infant Formula." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455562/all/The_long_term_suitability_of_hydrolysed_infant_formula.
The long-term suitability of hydrolysed infant formula. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455562/all/The_long_term_suitability_of_hydrolysed_infant_formula. Accessed October 19, 2019.
The long-term suitability of hydrolysed infant formula. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/455562/all/The_long_term_suitability_of_hydrolysed_infant_formula
The Long-term Suitability of Hydrolysed Infant Formula [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455562/all/The_long_term_suitability_of_hydrolysed_infant_formula.
TY - ELEC
T1 - The long-term suitability of hydrolysed infant formula
ID - 455562
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455562/all/The_long_term_suitability_of_hydrolysed_infant_formula
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine